The Popularity of the Legal Cannabis Industry

NEW YORK, April 20, 2017 /PRNewswire/ --

According to a report published by Grand View Research, Inc. the global medical cannabis market is expected to reach a value of USD 55.8 billion by 2025. The projection is largely based on the success the industry has made in recent years. By the end of 2016, Washington D.C., along with 28 states chose to legalize cannabis for medical uses. In 2016, states such as Arkansas, Florida, North Dakota, Ohio, and Pennsylvania passed legislations for legalizing the use of cannabis for medical purposes such as chemotherapies and pain management. The growing number of states and countries around the world, where the industry is gaining popularity, is getting legalized is one of the crucial factors driving the demand over the coming few years. Naturally Splendid Enterprises Ltd. (OTC: NSPDF) (TSX-V: NSP), Vitality Biopharma, Inc. (OTC: VBIO), Mentor Capital, Inc. (OTC: MNTR), Mountain High Acquisitions Corp. (OTC: MYHI), GB Sciences, Inc. (OTC: GBLX)

A major share of the legal cannabis is based on Cannabidiol (CBD) products. This is the part of the cannabis plant that is typically used for health reasons and not for recreational purposes. The Hemp Business Journal estimates that the CBD market will grow to a $2.1 billion market in consumer sales by 2020 with $450 million of those sales coming from hemp-based sources. That's a 700% increase from 2016. Forbes reported, that in 2015, the market for consumer sales of hemp-derived CBD products was $90 million, plus another $112 million in marijuana-derived CBD products which were sold through dispensaries - bringing a total CBD market to $202 million last year.

Naturally Splendid Enterprises Ltd. (OTCQB: NSPDF) (TSX-V: NSP) earlier this morning it was announced, "They have begun shipments of bulk hemp seeds to South Korea with the first container having left Vancouver on April 14, 2017. Additionally, the Company has entered into an Exclusive Sales Agreement with Laguna Blends to market and distribute a complete line of CBD formulated, cosmeteutical products that will be launched at Seoul Food & Hotel 2017 where the Company is an official delegate in the Canadian Pavilion."

Naturally Splendid CEO, Mr. Dave Eto states, "We are pleased to be resuming shipments of bulk hemp seed to South Korea. The Company had robust export sales in the first two quarters of 2016 before encountering a production interruption in Q3. I am pleased to report, the production issues have been resolved and we will be looking to re-establish our presence for bulk hemp products into South Korea with this shipment being evidence of that. Additionally, I am pleased to announce an Exclusive Sales Agreement with Laguna Blends to market and distribute a CBD formulated cosmeceutical line. These additional CBD formulated products will augment the CBD formulated products Naturally Splendid launched at FOODEX JAPAN this past March. Naturally Splendid President, Mr. Craig Goodwin will be meeting with our clients to discuss further business opportunities as well as seeking new business opportunities while attending the Seoul Food & Hotel tradeshow".

The Company will be launching the entire roster of CBD formulated products at Seoul Food & Hotel 2017 May 15-19. In addition, the Company will be presenting HempOmega™, bulk hemp seeds, a Korean branded NATERA® hemp seed line, as well as an array of formulated powdered fruit and vegetable ingredients."

Exclusive Sales Agreement - The details of the Exclusive Sales Agreement with Laguna Blends is as follows. Naturally Splendid's wholly owned U.S. subsidiary has signed an exclusive sales agreement with Laguna Blends for a complete suite of CBD formulated cosmeceutical products. The product line is comprised of seven custom formulated, CBD infused products that include anti-aging formulations. The Exclusive Sales Agreement is for a term of three (3) years, provided Naturally Splendid reaches certain cumulative sales volumes, and covers the territories of Japan and South Korea, as well as additional countries. The additional countries will be announced on a timely basis as the strategic marketing plan is implemented to cover these multiple territories.

Vitality Biopharma, Inc. (OTCQB: VBIO) is dedicated to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. On March 30th, 2017, the company announced that it has positive results indicating a new use for the Company's proprietary prodrug cannabinoid delivery platform. The company found that cannabidiol (CBD) universally inhibited cell growth at concentrations similar to established chemotherapeutics. Vitality also found that its cannabidiol prodrug was not toxic to the human cells at the concentrations tested, demonstrating the relative safety of its prodrug delivery system.

Mentor Capital, Inc. (OTCQB: MNTR) is a public operating company that acquires and provides liquidity for medical and social use cannabis companies. Recently, the company announced it has initiated funding for its GlauCanna venture for the use of medical marijuana in the treatment of glaucoma patients. Mentor will provide funding and business management for any commercial development and holds an 80% interest. "One of GlauCanna's first steps will be the completion of its dose response curve study which Mentor Capital is now funding," said Chet Billingsley, CEO Mentor Capital.

Mountain High Acquisitions Corp. (OTCQB: MYHI) is a holding company focused on the commercial hemp and CBD products industries. The company's first acquisition in this sector is GreenLife BotaniX, Inc. GreenLife is focused on the development and sale of products containing and featuring non-psychoactive CBD (cannabidiol) derived from hemp oil and sold under the retail brand name 'SuperCBD'. GreenLife currently features over a dozen CBD-based products on its e-commerce website, including four primary flagship products; 'Super CBD Drops' - a high-potency vanilla flavored vegan hemp oil tincture, 'Super CBD Lotion' - a CBD lotion made with a unique blend of CBD, eucalyptus oil, and vitamins and minerals, 'Super CBD Lip Balm' - a medicated ointment intended for a variety of skin problems, cuts and rashes, and 'Super CBD Pills' - a concentrated CBD dose in pill form for easy ingestion.

GB Sciences, Inc. (OTCQB: GBLX) is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development. Recently, GB Sciences and Arizona-based Kush Cups signed an agreement to produce cannabis-infused products in the state of Nevada. GB Sciences utilizes advanced propagation technology, raw tissue, and grows in medical-grade clean rooms, so that the venture is ensured of consistent cannabis ingredients for its infused products. The company will grow the cannabis in their state-of-the-art Cultivation Labs facility in Las Vegas and distribute cannabis-infused Keurig-compatible K-Cups, hot and cold brew coffees as well as infused teas.

Please SIGN UP NOW at http://www.FinancialBuzz.com To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"

Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com    

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. Financialbuzz.com has not been compensated directly by any of the companies mentioned here in this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For this release, FinancialBuzz.com has been compensated a total of ten thousand dollars for financial news dissemination and pr services by a third party non affiliate for naturally splendid enterprises ltd. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit: http://www.financialbuzz.com

Media Contact:
info@financialbuzz.com
+1-877-601-1879

Url: http://www.FinancialBuzz.com

SOURCE FinancialBuzz.com